Creatine phosphate improves myocardial function and myocardial enzyme profile in children with myocarditis
Shaoli Lin1, Junbo Yang2, Jing Yu3
1Department of Pediatrics, Yantaishan Hospital, Yantai, China.
Insights
Creatine phosphate effectively treats pediatric myocarditis, improving heart function and reducing myocardial damage in children. This treatment offers a safe and beneficial option for improving cardiac outcomes.
Area of Science:
- Pediatric Cardiology
- Cardiovascular Pharmacology
Background:
- Myocarditis in children can lead to significant cardiac dysfunction.
- Effective therapeutic strategies for pediatric myocarditis are crucial.
Purpose of the Study:
- To evaluate the efficacy and safety of creatine phosphate in treating pediatric myocarditis.
- To compare creatine phosphate treatment with standard care in children with myocarditis.
Main Methods:
- A comparative study involving two groups of children diagnosed with myocarditis.
- The observation group received creatine phosphate in addition to sodium fructose diphosphate.
- The control group received only sodium fructose diphosphate.
Main Results:
- Children treated with creatine phosphate showed improved myocardial enzyme profiles.
- Cardiac function was significantly better in the creatine phosphate group compared to the control group.
- The overall treatment effective rate was higher in the observation group.
Conclusions:
- Creatine phosphate demonstrates significant benefits in improving myocardial function and reducing cardiac damage in pediatric myocarditis.
- The treatment exhibits a high safety profile, supporting its clinical applicability.
- Creatine phosphate is a promising therapeutic agent for pediatric myocarditis, warranting further clinical promotion.
Abstract:
Myocarditis in children is more common in clinical practice, which can cause different degrees of cardiac function damage. We investigated the effects of creatine phosphate in the treatment of myocarditis in children. Children in the control group were treated with sodium fructose diphosphate, and children in the observation group were treated with creatine phosphate on the basis of the control group. After treatment, the myocardial enzyme profile and cardiac function of children in the observation group were better than the control group. The total effective rate of treatment for children in the observation group was higher than that in the control group. In conclusion, creatine phosphate could significantly improve myocardial function, improve myocardial enzyme profile and reduce myocardial damage in children with pediatric myocarditis and had a high safety of use, which was worthy of clinical promotion.
Related Concept Videos
Myocarditis III: Medical Management
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Cardiomyopathy II: Dilated Cardiomyopathy
Myocarditis II: Clinical Features and Diagnostic Tests
Cardiomyopathy V: Interprofessional Care
Myocarditis I: Introduction


